G D Hall
Overview
Explore the profile of G D Hall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
298
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goranova T, Ennis D, Piskorz A, Macintyre G, Lewsley L, Stobo J, et al.
Br J Cancer
. 2019 Mar;
120(8):868.
PMID: 30862952
This article was originally published under a CC BY NC SA License, but has now been made available under a CC BY 4.0 License.
2.
Goranova T, Ennis D, Piskorz A, Macintyre G, Lewsley L, Stobo J, et al.
Br J Cancer
. 2017 Mar;
116(10):1294-1301.
PMID: 28359078
Background: Investigating tumour evolution and acquired chemotherapy resistance requires analysis of sequential tumour material. We describe the feasibility of obtaining research biopsies in women with relapsed ovarian high-grade serous carcinoma...
3.
Glasspool R, Brown R, Gore M, Rustin G, McNeish I, Wilson R, et al.
Br J Cancer
. 2014 Mar;
110(8):1923-9.
PMID: 24642620
Background: Our previous laboratory and clinical data suggested that one mechanism underlying the development of platinum resistance in ovarian cancer is the acquisition of DNA methylation. We therefore tested the...
4.
Jennings V, Ilett E, Scott K, West E, Vile R, Pandha H, et al.
Int J Cancer
. 2013 Aug;
134(5):1091-101.
PMID: 23982804
Reovirus is an oncolytic virus (OV), which acts by both direct tumor cell killing and priming of antitumor immunity. A major obstacle for effective oncolytic virotherapy is effective delivery of...
5.
Harvey T, Hennig I, Shnyder S, Cooper P, Ingram N, Hall G, et al.
Cancer Gene Ther
. 2011 Aug;
18(11):773-84.
PMID: 21836632
Hypoxia is an important factor in tumor growth. It is associated with resistance to conventional anticancer treatments. Gene therapy targeting hypoxic tumor cells therefore has the potential to enhance the...
6.
Bruning-Richardson A, Bond J, Alsiary R, Richardson J, Cairns D, McCormack L, et al.
Br J Cancer
. 2011 Apr;
104(10):1602-10.
PMID: 21505456
Background: The clinico-pathological and molecular heterogeneity of epithelial ovarian cancer (EOC) complicates its early diagnosis and successful treatment. Highly aneuploid tumours and the presence of ascitic fluids are hallmarks of...
7.
Ingram N, MacCormac L, Oxley N, Burns P, Hall G
Cancer Gene Ther
. 2010 Jun;
17(10):684-93.
PMID: 20539322
Adenovirus is the most frequently used virus in gene therapy clinical trials. There have been conflicting reports on the ability of adenovirus to transduce primary ovarian cancer samples and the...
8.
Harvey T, Burdon D, Steele L, Ingram N, Hall G, Selby P, et al.
Gene Ther
. 2010 Apr;
17(8):1000-10.
PMID: 20410926
We have assessed the ability of bispecific fusion proteins to improve adenovirus-mediated transfer of therapeutic and marker transgenes. We constructed an expression vector that can be easily modified to synthesize...
9.
Hewitt M, Anderson K, Hall G, Weston M, Hutson R, Wilkinson N, et al.
BJOG
. 2007 Jan;
114(1):46-50.
PMID: 17233859
Objectives: To evaluate the use of image-guided biopsy (IGB) in routine clinical practice to obtain site-specific diagnoses in women presenting with peritoneal carcinomatosis (PC). Study Design: Retrospective case study. Setting:...
10.
Hewitt M, Hall G, Wilkinson N, Perren T, Lane G, Spencer J
Int J Gynecol Cancer
. 2006 Mar;
16 Suppl 1:108-10.
PMID: 16515576
When women with a history of breast cancer present with peritoneal carcinomatosis, the differential diagnosis lies between recurrent breast cancer or a new primary tumor. This scenario is of particular...